Net Cash Provided by (Used in) Operating Activities |
-1.82M |
USD |
-386% |
Q1 2023 |
Q1 2023 |
Common Stock, Shares Authorized |
301M |
shares |
0% |
Q2 2023 |
Q2 2023 |
Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q3 2023 |
Q3 2023 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
-1.42M |
USD |
-1439% |
Q1 2023 |
Q1 2023 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
162K |
USD |
+209% |
Q3 2023 |
Q3 2023 |
Deferred Tax Assets, Valuation Allowance |
650K |
USD |
+43.6% |
Q4 2022 |
FY 2022 |
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent |
0.21 |
pure |
|
Q1 2023 |
Q1 2023 |
Deferred Tax Assets, Gross |
650K |
USD |
+43.6% |
Q4 2022 |
FY 2022 |
Deferred Income Tax Expense (Benefit) |
95K |
USD |
+1262% |
Q1 2022 |
Q1 2022 |
Preferred Stock, Shares Issued |
0 |
shares |
|
Q3 2023 |
Q3 2023 |
Preferred Stock, Shares Authorized |
1M |
shares |
0% |
Q3 2023 |
Q3 2023 |
Unrecognized Tax Benefits |
0 |
USD |
|
Q3 2023 |
Q3 2023 |
Additional Paid in Capital |
0 |
USD |
-100% |
Q1 2022 |
Q1 2022 |
Preferred Stock, Shares Outstanding |
0 |
shares |
|
Q3 2023 |
Q3 2023 |
Preferred Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q3 2023 |
Q3 2023 |